🇺🇸 FDA
Patent

US 10039819

Attenuated Mannheimia haemolytica strains

granted A61KA61K2039/522A61K2039/543

Quick answer

US patent 10039819 (Attenuated Mannheimia haemolytica strains) held by The United States of America, as represented by the Secretary of Agriculture expires Mon Aug 02 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary of Agriculture
Grant date
Tue Aug 07 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 02 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K2039/522, A61K2039/543, A61K2039/552, A61K2039/70